CXCL9 treatment has been disclosed to attenuate 5-Fu induced mucositis (Han et al., 2011), however, it exacerbates 5-Fu induced acute intestinal damage (Lu et al., 2015). The gene discussed is CXCL9; the disease is mucositis.